| 000 | 01607 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517174511.0 | ||
| 264 | 0 | _c20180514 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1525-3171 | ||
| 024 | 7 |
_a10.3382/ps/pex163 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSong, Yalu | |
| 245 | 0 | 0 |
_aAbnormal histopathology, fat percent and hepatic apolipoprotein A I and apolipoprotein B100 mRNA expression in fatty liver hemorrhagic syndrome and their improvement by soybean lecithin. _h[electronic resource] |
| 260 |
_bPoultry science _cOct 2017 |
||
| 300 |
_a3559-3563 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnimal Feed _xanalysis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApolipoprotein A-I _xgenetics |
| 650 | 0 | 4 |
_aApolipoprotein B-100 _xgenetics |
| 650 | 0 | 4 |
_aAvian Proteins _xgenetics |
| 650 | 0 | 4 | _aBody Fat Distribution |
| 650 | 0 | 4 | _aChickens |
| 650 | 0 | 4 |
_aDiet _xveterinary |
| 650 | 0 | 4 |
_aDietary Supplements _xanalysis |
| 650 | 0 | 4 |
_aFatty Liver _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aLecithins _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 |
_aPoultry Diseases _xdrug therapy |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aGlycine max _xchemistry |
| 700 | 1 | _aRuan, Jiming | |
| 700 | 1 | _aLuo, Junrong | |
| 700 | 1 | _aWang, Tiancheng | |
| 700 | 1 | _aYang, Fei | |
| 700 | 1 | _aCao, Huabin | |
| 700 | 1 | _aHuang, Jianzhen | |
| 700 | 1 | _aHu, Guoliang | |
| 773 | 0 |
_tPoultry science _gvol. 96 _gno. 10 _gp. 3559-3563 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3382/ps/pex163 _zAvailable from publisher's website |
| 999 |
_c27593073 _d27593073 |
||